哪些银屑病患者会发展为银屑病关节炎？
Which Psoriasis Patients Develop Psoriatic Arthritis?
作者信息
Busse Kristine, Liao Wilson
机构信息
Department of Dermatology and Psoriasis Treatment Center, University of California-San Francisco, San Francisco, California.
出版信息
Psoriasis Forum. 2010 Winter;16(4):17-25.
Abstract
Psoriatic arthritis is a major comorbidity of psoriasis that significantly impairs quality of life and physical function. Because skin lesions classically precede joint symptoms, dermatologists are in a unique position to identify patients at risk for psoriatic arthritis before irreversible joint damage occurs. Here we review the literature to identify the clinical and genetic factors most highly associated with development of psoriatic arthritis, with the goal of assisting dermatologists in risk-stratifying their psoriasis patients.
摘要
银屑病关节炎是银屑病的一种主要合并症，会显著损害生活质量和身体功能。由于皮肤病变通常先于关节症状出现，皮肤科医生处于独特地位，能够在不可逆转的关节损伤发生之前识别出有银屑病关节炎风险的患者。在此，我们回顾文献，以确定与银屑病关节炎发生最密切相关的临床和遗传因素，目的是帮助皮肤科医生对银屑病患者进行风险分层。
相似文献
1
Which Psoriasis Patients Develop Psoriatic Arthritis?
Psoriasis Forum. 2010 Winter;16(4):17-25.
2
Axial psoriatic arthritis: An update for dermatologists.
J Am Acad Dermatol. 2021 Jan;84(1):92-101. doi: 10.1016/j.jaad.2020.05.089. Epub 2020 Jul 31.
3
Nail psoriasis as a predictor of the development of psoriatic arthritis.
Actas Dermosifiliogr. 2015 Jul-Aug;106(6):452-7. doi: 10.1016/j.ad.2015.02.005. Epub 2015 May 27.
4
Psoriatic arthritis for dermatologists.
J Dermatolog Treat. 2020 Nov;31(7):662-679. doi: 10.1080/09546634.2019.1605142. Epub 2019 May 7.
5
Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
Drugs. 2014 Mar;74(4):423-41. doi: 10.1007/s40265-014-0191-y.
6
Musculoskeletal Imaging for Dermatologists: Techniques in the Diagnosis and Management of Psoriatic Arthritis.
Dermatol Ther (Heidelb). 2021 Aug;11(4):1199-1216. doi: 10.1007/s13555-021-00565-1. Epub 2021 Jun 18.
7
[Differential diagnostic spectrum of psoriasis vs. psoriatic arthritis in skin and joints].
Z Rheumatol. 2017 Aug;76(6):484-494. doi: 10.1007/s00393-017-0340-2.
8
Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study.
Arthritis Res Ther. 2018 May 31;20(1):102. doi: 10.1186/s13075-018-1601-4.
9
Diagnosing Psoriatic Arthritis from the Dermatologist's View.
J Lifestyle Med. 2013 Sep;3(2):85-90. Epub 2013 Sep 30.
10
MANAGEMENT OF PSORIATIC ARTHRITIS: SHOULD THE INTERACTION BETWEEN DERMATOLOGISTS AND RHEUMATOLOGISTS IN CLINICAL PRACTICE BE INTENSIFIED?
J Biol Regul Homeost Agents. 2015 Jul-Sep;29(3):547-61.
引用本文的文献
1
Relative sensitivity and preference of indicators in pharmaceutical trials of psoriasis and psoriatic arthritis.
Eur J Med Res. 2025 Aug 26;30(1):803. doi: 10.1186/s40001-025-02995-5.
2
Single-cell RNA sequencing of circulating immune cells supports inhibition of and translation as psoriatic arthritis biomarkers.
Front Immunol. 2025 Feb 7;16:1483393. doi: 10.3389/fimmu.2025.1483393. eCollection 2025.
3
Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United States.
Psoriasis (Auckl). 2024 Jun 22;14:63-78. doi: 10.2147/PTT.S430151. eCollection 2024.
4
State of the Art Review on the Treatment of Psoriatic Disease.
Mediterr J Rheumatol. 2024 Jan 31;35(1):66-72. doi: 10.31138/mjr.040123.sot. eCollection 2024 Mar.
5
Machine Learning Approaches for Predicting Psoriatic Arthritis Risk Using Electronic Medical Records: Population-Based Study.
J Med Internet Res. 2023 Mar 28;25:e39972. doi: 10.2196/39972.
6
DNA Methylation Patterns in CD8 T Cells Discern Psoriasis From Psoriatic Arthritis and Correlate With Cutaneous Disease Activity.
Front Cell Dev Biol. 2021 Oct 21;9:746145. doi: 10.3389/fcell.2021.746145. eCollection 2021.
7
Prevalence of psoriatic arthritis among patients with plaque psoriasis: a Brazilian retrospective study.
Sao Paulo Med J. 2021 Aug-Sep;139(5):476-480. doi: 10.1590/1516-3180.2020.0629.16032021.
8
Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis.
Acta Derm Venereol. 2021 Oct 11;101(10):adv00566. doi: 10.2340/00015555-3879.
9
Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis.
J Rheumatol. 2021 Oct;48(10):1559-1565. doi: 10.3899/jrheum.201123. Epub 2021 Apr 15.
10
Long-term Outcomes and Prognosis in New-Onset Psoriasis.
JAMA Dermatol. 2021 Apr 14;157(6):1-8. doi: 10.1001/jamadermatol.2021.0734.
本文引用的文献
1
Genome-wide association analysis identifies three psoriasis susceptibility loci.
Nat Genet. 2010 Nov;42(11):1000-4. doi: 10.1038/ng.693. Epub 2010 Oct 17.
2
Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2.
Nat Genet. 2010 Nov;42(11):991-5. doi: 10.1038/ng.689. Epub 2010 Oct 17.
3
Obesity in early adulthood as a risk factor for psoriatic arthritis.
Arch Dermatol. 2010 Jul;146(7):721-6. doi: 10.1001/archdermatol.2010.141.
4
Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria.
Clin Exp Rheumatol. 2010 May-Jun;28(3):304-10. Epub 2010 Jun 23.
5
Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT.
Arthritis Res Ther. 2010;12(3):R113. doi: 10.1186/ar3049. Epub 2010 Jun 10.
6
Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis.
J Dermatol. 2010 May;37(5):426-30. doi: 10.1111/j.1346-8138.2009.00745.x.
7
Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature.
J Eur Acad Dermatol Venereol. 2010 Apr;24 Suppl 2:31-5. doi: 10.1111/j.1468-3083.2009.03565.x.
8
Genetic susceptibility factors for psoriatic arthritis.
Curr Opin Rheumatol. 2010 Mar;22(2):152-6. doi: 10.1097/BOR.0b013e32833669d2.
9
Psoriasis comorbidities.
J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2:S77-87. doi: 10.2310/7750.2009.00024.
10
The prevalence of psoriatic arthritis in people with psoriasis.
Arthritis Rheum. 2009 Oct 15;61(10):1373-8. doi: 10.1002/art.24608.
Zotero 插件